DURHAM, N.C., Jan. 7, 2014 (GLOBE NEWSWIRE) -- EMRISE CORPORATION (OTCQB:EMRI), a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced that its XCEL Power Systems, Ltd. subsidiary in England has recently been awarded SC21 Bronze level supply chain accreditation.
SC21 is an industry program designed to accelerate the competitiveness of the aerospace and defense industry in the United Kingdom by raising the performance of the industry's supply chains. SC21 accredited companies are committed to developing supply chains that ensure they remain competitive and able to deliver increased value to their customers.
EMRISE Chairman and Chief Executive Officer Carmine T. Oliva said by attaining SC21 supply chain accreditation in the U.K., XCEL achieved yet another key industry milestone. "The addition of this important accreditation to XCEL's existing AS9100 quality management system and other industry accreditations highlights our ongoing commitment to deliver quality and continuous process improvements to our growing base of customers. These accreditations also further differentiate XCEL from many of its competitors, increase its strength in the aerospace and defense market, and contribute to the overall enhancement of its value.
"The SC21 Bronze award is a reflection of the commitment and hard work by the entire team at XCEL," Oliva added. "The SC21 process encompasses every element of the business. It has been wholeheartedly embraced by XCEL and the benefits of the SC21 journey have already been felt, both internally and externally."
About XCEL Power Systems, Ltd
Since 1956, XCEL Power Systems based in Kent England has been at the forefront of the design and manufacture of Low Voltage and High Voltage Switch Mode Custom Power Supplies. Its products are used in harsh environment applications across a wide range of equipment. XCEL's key customers operate in the defense, aerospace, medical, transport and telecommunication markets.
About EMRISE Corporation
EMRISE designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. EMRISE products perform key functions such as power supply and power conversion; radio frequency (RF) and microwave signal processing; and network access to public and private communications networks. The use of its network products in public and private, legacy and latest Ethernet and Internet Protocol (IP) networks is a primary growth driver for the Company's Communications Equipment business units. The use of its power supplies, RF and microwave signal processing devices and subsystems in on-board In-Flight Entertainment and Connectivity systems is a primary growth driver for the Company's Electronic Devices business units. EMRISE serves the worldwide base of customers it has built in North America, Europe and Asia through operations in the United States, England and France. For more information on EMRISE, go to www.emrise.com.
EMRISE common stock trades under the symbol EMRI on OTCQB, the venture marketplace for companies that are current in their reporting with a U.S. regulator. Investors can find Real-Time quotes and market information for EMRISE at www.otcmarkets.com.
Safe Harbor Statement under Private Securities Litigation Reform Act of 1995
With the exception of historical information, certain matters discussed in this press release, including, but not limited to, EMRISE's belief that the SC21, AS9100 and other industry accreditations further differentiate XCEL from many of its competitors, increase its strength in the aerospace and defense market, and contribute to the overall enhancement of its value are forward-looking statement involving risks and uncertainties. Actual future results of EMRISE could differ from those statements. EMRISE also refers you to those factors contained in the "Risk Factors" Section of EMRISE's Annual Report on Form 10-K for the year ended December 31, 2012, its Quarterly Reports on Form 10-Q, Current Reports on Form 8-K filed recently, and other EMRISE SEC filings.